Presentation is loading. Please wait.

Presentation is loading. Please wait.

Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs)

Similar presentations


Presentation on theme: "Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs)"— Presentation transcript:

1 Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets  Diana Brixner, PhD, RPh, FAMCP, Nikos Maniadakis, BSc, MSc, PhD, FESC, Zoltán Kaló, MSc, PhD, Shanlian Hu, MD, MSc, Jie Shen, MBA, Kalman Wijaya, BSc, Pharm, MBA  Value in Health Regional Issues  Volume 13, Pages 1-6 (September 2017) DOI: /j.vhri Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2 Fig. 1 Mean ranking of 22 criteria in MCDA simple scoring. API, active pharmaceutical ingredient; MCDA, multicriteria decision analysis. Value in Health Regional Issues  , 1-6DOI: ( /j.vhri ) Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions


Download ppt "Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs)"

Similar presentations


Ads by Google